Annual Total Long Term Liabilities
$15.83 M
+$220.00 K+1.41%
31 December 2023
Summary:
Vanda Pharmaceuticals annual total long term liabilities is currently $15.83 million, with the most recent change of +$220.00 thousand (+1.41%) on 31 December 2023. During the last 3 years, it has risen by +$1.58 million (+11.08%). VNDA annual total long term liabilities is now -99.63% below its all-time high of $4.27 billion, reached on 01 December 2003.VNDA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$14.80 M
-$262.00 K-1.74%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly total long term liabilities is currently $14.80 million, with the most recent change of -$262.00 thousand (-1.74%) on 30 September 2024. Over the past year, it has increased by +$1.13 million (+8.30%). VNDA quarterly long term liabilities is now -91.35% below its all-time high of $171.15 million, reached on 31 December 2009.VNDA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.4% | +8.3% |
| 3 y3 years | +11.1% | +2.4% |
| 5 y5 years | +328.7% | +9.3% |
VNDA Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +11.1% | -6.5% | +38.4% |
| 5 y | 5 years | at high | +328.7% | -6.5% | +38.4% |
| alltime | all time | -99.6% | >+9999.0% | -91.3% | >+9999.0% |
Vanda Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.80 M(-1.7%) |
| June 2024 | - | $15.06 M(-1.8%) |
| Mar 2024 | - | $15.35 M(-3.1%) |
| Dec 2023 | $15.83 M(+1.4%) | $15.83 M(+15.8%) |
| Sept 2023 | - | $13.67 M(-5.0%) |
| June 2023 | - | $14.39 M(-4.1%) |
| Mar 2023 | - | $15.00 M(-3.9%) |
| Dec 2022 | $15.61 M(+8.1%) | $15.61 M(+15.6%) |
| Sept 2022 | - | $13.51 M(+11.1%) |
| June 2022 | - | $12.15 M(+13.7%) |
| Mar 2022 | - | $10.69 M(-26.0%) |
| Dec 2021 | $14.45 M(+1.3%) | $14.45 M(-0.0%) |
| Sept 2021 | - | $14.45 M(+0.1%) |
| June 2021 | - | $14.44 M(+4.8%) |
| Mar 2021 | - | $13.78 M(-3.3%) |
| Dec 2020 | $14.25 M(+7.2%) | $14.25 M(+2.0%) |
| Sept 2020 | - | $13.97 M(+3.9%) |
| June 2020 | - | $13.46 M(+4.2%) |
| Mar 2020 | - | $12.92 M(-2.9%) |
| Dec 2019 | $13.30 M(+260.1%) | $13.30 M(-1.8%) |
| Sept 2019 | - | $13.55 M(+2.5%) |
| June 2019 | - | $13.21 M(-2.0%) |
| Mar 2019 | - | $13.49 M(+265.2%) |
| Dec 2018 | $3.69 M(+0.5%) | $3.69 M(-13.7%) |
| Sept 2018 | - | $4.28 M(-10.4%) |
| June 2018 | - | $4.77 M(+13.2%) |
| Mar 2018 | - | $4.22 M(+14.7%) |
| Dec 2017 | $3.67 M(-87.2%) | $3.67 M(-0.7%) |
| Sept 2017 | - | $3.70 M(-3.0%) |
| June 2017 | - | $3.82 M(+5.7%) |
| Mar 2017 | - | $3.61 M(-87.4%) |
| Dec 2016 | $28.72 M(+0.1%) | $28.72 M(+0.4%) |
| Sept 2016 | - | $28.60 M(-0.2%) |
| June 2016 | - | $28.66 M(-0.1%) |
| Mar 2016 | - | $28.69 M(-0.1%) |
| Dec 2015 | $28.71 M(+825.7%) | $28.71 M(-0.0%) |
| Sept 2015 | - | $28.72 M(-0.1%) |
| June 2015 | - | $28.75 M(-2.1%) |
| Mar 2015 | - | $29.38 M(+847.4%) |
| Dec 2014 | $3.10 M(-95.3%) | $3.10 M(-92.1%) |
| Sept 2014 | - | $39.27 M(-16.4%) |
| June 2014 | - | $46.99 M(-13.9%) |
| Mar 2014 | - | $54.59 M(-17.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $66.37 M(-28.8%) | $66.37 M(-9.3%) |
| Sept 2013 | - | $73.18 M(-8.5%) |
| June 2013 | - | $79.99 M(-7.7%) |
| Mar 2013 | - | $86.69 M(-7.1%) |
| Dec 2012 | $93.28 M(-20.6%) | $93.28 M(-6.6%) |
| Sept 2012 | - | $99.82 M(-6.2%) |
| June 2012 | - | $106.37 M(-5.9%) |
| Mar 2012 | - | $113.02 M(-3.8%) |
| Dec 2011 | $117.53 M(-18.6%) | $117.53 M(-5.5%) |
| Sept 2011 | - | $124.42 M(-5.1%) |
| June 2011 | - | $131.04 M(-4.9%) |
| Mar 2011 | - | $137.73 M(-4.6%) |
| Dec 2010 | $144.34 M(-15.7%) | $144.34 M(-4.5%) |
| Sept 2010 | - | $151.10 M(-4.3%) |
| June 2010 | - | $157.86 M(-4.1%) |
| Mar 2010 | - | $164.54 M(-3.9%) |
| Dec 2009 | $171.15 M(>+9900.0%) | $171.15 M(>+9900.0%) |
| Sept 2009 | - | $505.80 K(+0.2%) |
| June 2009 | - | $504.80 K(+0.2%) |
| Mar 2009 | - | $503.80 K(+0.2%) |
| Dec 2008 | $502.80 K(+42.0%) | $502.80 K(+1.2%) |
| Sept 2008 | - | $496.80 K(+1.2%) |
| June 2008 | - | $490.80 K(+16.2%) |
| Mar 2008 | - | $422.40 K(+19.3%) |
| Dec 2007 | $354.00 K(-10.9%) | $354.00 K(+26.1%) |
| Sept 2007 | - | $280.70 K(+10.6%) |
| June 2007 | - | $253.70 K(-43.4%) |
| Mar 2007 | - | $448.20 K(+12.8%) |
| Dec 2006 | $397.30 K(+1528.3%) | $397.30 K(+63.9%) |
| Sept 2006 | - | $242.40 K(+38.3%) |
| June 2006 | - | $175.30 K(+34.5%) |
| Mar 2006 | - | $130.30 K(+434.0%) |
| Dec 2005 | $24.40 K(-86.9%) | $24.40 K |
| Dec 2004 | $185.90 K(-100.0%) | - |
| Dec 2003 | $4.27 B(+3.3%) | - |
| Dec 2002 | $4.13 B(+66.9%) | - |
| Dec 2001 | $2.48 B(-6.8%) | - |
| Dec 2000 | $2.66 B(+29.7%) | - |
| Dec 1999 | $2.05 B(-0.1%) | - |
| Dec 1998 | $2.05 B(+114.4%) | - |
| Dec 1997 | $956.70 M(+295.3%) | - |
| Dec 1996 | $242.00 M(-12.7%) | - |
| Dec 1995 | $277.20 M(+3.3%) | - |
| Dec 1994 | $268.40 M | - |
FAQ
- What is Vanda Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Vanda Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Vanda Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of VNDA is $15.83 M
What is the all time high annual total long term liabilities for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual total long term liabilities is $4.27 B
What is Vanda Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, VNDA annual total long term liabilities has changed by +$220.00 K (+1.41%)
What is Vanda Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of VNDA is $14.80 M
What is the all time high quarterly long term liabilities for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly total long term liabilities is $171.15 M
What is Vanda Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, VNDA quarterly total long term liabilities has changed by +$1.13 M (+8.30%)